An Afghan vlogger has claimed that Indian medicines that are cheaper and work better are fast-replacing Pakistani drugs.

Pharma stocks rise as Cipla faces supply issues, Zydus gains FDA approval, and Biocon secures funding through a QIP.

Non-compliance with the mandatory revised Schedule M manufacturing protocols has landed Himachal Pradesh’s pharmaceutical ...

A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort ...

Eastern North Carolina's biomanufacturing sector is experiencing unprecedented growth, with the region capturing the lion's ...

FOSHAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- The construction industry is experiencing a materials ...

Johnson & Johnson unveils US$4bn build programme for pharmaceutical manufacturing in Pennsylvania and North Carolina ...

Production is targeted to begin in 2026. It is expected to create about 800 direct jobs and thousands of indirect jobs in the ...

Sharp Sterile Manufacturing is investing $28 million to expand equipment at its Lee facility, a move expected to double ...

Greenfield officials will consider granting a rare 15-year tax abatement.

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Indiana Gov. Mike Braun today highlighted the surge in Indiana’s life sciences sector, with three major industry expansions ...